1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow Adenocarcinoma, Clear Cell: new trials by email Literature Review of Adenocarcinoma, Clear Cell trials Research Report on Adenocarcinoma, Clear Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell Carcinoma Lymphodepleting chemotherapy, Dexamethasone, Fludarabine - Clear Cell Carcinoma, Phase 1 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 30 | 2025-09-25 | 2026-04-29 |
| A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers KFA115, pembrolizumab - Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma | Phase 1 | Active not recruiting | Novartis Pharmaceuticals | 126 | 2022-10-26 | 2026-10-20 |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas alemtuzumab, fludarabine, sirolimus - Ewing Sarcoma, Gastrointestinal Tumor | Phase 1 | Completed | St. Jude Children's Research Hospital | 23 | 2012-08-20 | 2026-02-06 |
Carcinoma, Renal Cell (2) · Melanoma (2) · Anus Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Esophageal Neoplasms (1) · Head and Neck Neoplasms (1) · Intestinal Neoplasms (1) · Kidney Neoplasms (1) · Lung Neoplasms (1)
Adenocarcinoma (3) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Digestive System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hemic and Lymphatic Diseases (2) · Kidney Diseases (2) · Lymphatic Diseases (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Neoplasms, Complex and Mixed (2) · Neoplasms, Nerve Tissue (2)
fludarabine (2) · Alemtuzumab (1) · Busulfan (1) · Dexamethasone (1) · Melphalan (1) · Sirolimus (1) · Stem Cell Transplantation (1) · pembrolizumab (1)
M.D. Anderson Cancer Center (1) · Novartis Pharmaceuticals (1) · St. Jude Children's Research Hospital (1)
United States (3) · Canada (1) · China (1) · France (1) · Germany (1) · Hong Kong (1) · Italy (1) · Japan (1) · Singapore (1) · South Korea (1) · Spain (1) · Taiwan (1)
Andrew C Johns, MD (1) · Brando Triplett, MD (1)